Cyclacel Pharmaceuticals Inc (CYCC)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Apr 26, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Price: 1.51 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 1.55 | 1.56 | 1.46 | 1.51 | 179950.0 |
Apr 25, 2024 | 1.78 | 1.987 | 1.41 | 1.60 | 3.458M |
Apr 24, 2024 | 1.86 | 2.350 | 1.85 | 2.300 | 551102.0 |
Apr 23, 2024 | 1.71 | 1.85 | 1.68 | 1.79 | 28374.00 |
Apr 22, 2024 | 1.80 | 1.93 | 1.73 | 1.75 | 25527.00 |
Apr 19, 2024 | 1.89 | 1.95 | 1.772 | 1.78 | 10391.00 |
Apr 18, 2024 | 1.91 | 1.96 | 1.81 | 1.85 | 37911.00 |
Apr 17, 2024 | 1.67 | 2.090 | 1.67 | 1.96 | 115080.0 |
Apr 16, 2024 | 1.52 | 1.72 | 1.52 | 1.67 | 48891.00 |
Apr 15, 2024 | 1.76 | 1.84 | 1.57 | 1.57 | 38778.00 |
Apr 12, 2024 | 1.91 | 1.91 | 1.76 | 1.76 | 29512.00 |
Apr 11, 2024 | 2.00 | 2.05 | 1.91 | 1.94 | 24158.00 |
Apr 10, 2024 | 2.09 | 2.11 | 1.95 | 2.05 | 38282.00 |
Apr 09, 2024 | 2.07 | 2.13 | 2.07 | 2.11 | 5730.00 |
Apr 08, 2024 | 2.05 | 2.140 | 2.05 | 2.11 | 24922.00 |
Apr 05, 2024 | 2.21 | 2.21 | 2.03 | 2.10 | 17941.00 |
Apr 04, 2024 | 2.13 | 2.193 | 2.12 | 2.193 | 3799.00 |
Apr 03, 2024 | 2.154 | 2.22 | 2.071 | 2.19 | 21579.00 |
Apr 02, 2024 | 2.00 | 2.149 | 2.00 | 2.12 | 20139.00 |
Apr 01, 2024 | 2.20 | 2.231 | 2.010 | 2.05 | 22065.00 |
Mar 28, 2024 | 1.99 | 2.14 | 1.99 | 2.110 | 46138.00 |
Mar 27, 2024 | 2.09 | 2.09 | 1.94 | 1.96 | 14688.00 |
Mar 26, 2024 | 2.11 | 2.18 | 1.820 | 1.92 | 107917.0 |
Mar 25, 2024 | 2.14 | 2.220 | 2.058 | 2.14 | 58529.00 |
Mar 22, 2024 | 2.09 | 2.23 | 2.07 | 2.188 | 36905.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.51
Minimum
Apr 26 2024
274.50
Maximum
Jan 10 2020
66.33
Average
55.50
Median
Sep 29 2020
Price Benchmarks
Corvus Pharmaceuticals Inc | 1.47 |
Oragenics Inc | 1.03 |
Relmada Therapeutics Inc | 3.835 |
Alpine Immune Sciences Inc | 64.56 |
MAIA Biotechnology Inc | 2.90 |
Price Related Metrics
Price to Book Value | 3.279 |
Earnings Yield | -1.77K% |
Market Cap | 1.991M |